Cost-effective In vivo and In vitro Mouse Models for Evaluating Anti-Cryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel and Baicalein.
Mingxiao LiuDi ZhangDongqiang WangXiaodong WuYing ZhangJigang YinGuan ZhuPublished in: The Journal of infectious diseases (2023)
Novel in vivo and in vitro models have been developed for cost-effective anti-cryptosporidial drug testing. Vorinostat, docetaxel, and baicalein show potential for repurposing and/or optimization for developing new anti-cryptosporidial drugs.